Glycine or taurine

Europe PMC · from cache · sorted by publication date

1. 1
   Gut microbiota and immunometabolism in obesity.

   Torres-Mayo A, Liébana-García R, Olivares M, Pellón A, Anguita J, Sanz Y. · 2026-05-05

   cited 1× open access unreviewed
2. 2
   The gut microbiome-bile acid-FXR interplay: a pivotal axis in metabolic and gastrointestinal diseases.

   Shou J, Fu T. · 2026-05-01

   open access unreviewed
3. 3
   Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases.

   Yang W, Hao C, Wang N, Xie J, Zhou B, Yang Z, Zheng A, Wei J, Li C, Xie C, Li H, Lei G, Zeng C. · 2026-04-22

   open access unreviewed
4. 4
   Circulatory dietary and gut-derived metabolites predict early cognitive decline.

   Connell E, Sami S, Khondoker M, Minihane AM, Pontifex MG, Müller M, McArthur S, Le Gall G, Vauzour D. · 2026-03-27

   cited 2× open access unreviewed
5. 5
   A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis.

   Biagioli M, Di Giorgio C, Marchianò S, Sensini B, Urbani G, Giannelli E, Lachi G, Massa C, Sette MR, Paniconi… · 2026-03-18

   cited 1× open access unreviewed
6. 6
   Gut microbiota‑derived metabolites in cardiovascular disease: Focus on trimethylamine N‑oxide, short‑chain fatty acids and bile acids (Review).

   Gao M, Hao Z, Li Y, Liu W, Zhang F. · 2026-06-11

   open access unreviewed
7. 7
   An orthogonal mammalian gene circuit for selective sensing of taurine-conjugated bile acids.

   Lu Z, Shi Y, Deng N, Zhang C. · 2026-07-22

   unreviewed
8. 8
   From extracellular entry to intracellular release: A water-assisted transport cycle for creatine in SLC6A8.

   Poudel P, Panday SK, Alexov E. · 2026-07-01

   open access unreviewed
9. 9
   Alcohol-related liver disease disrupts bile acid homeostasis and gut microbial bile acid metabolism.

   Keller MI, de Zawadzki A, Thiele M, Suvitaival T, Sulek K, Kuhn M, Schudoma C, Podlesny D, Nishijima S, Fulla… · 2026-04-02

   open access unreviewed
10. 10
    Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective

    · 2026-06-01

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.